Abstract
Background: Increasing evidence shows that electroacupuncture pretreatment (EP) plays a crucial role in cerebral ischemia-reperfusion (I/R) injury, and cerebral I/R injury is the most serious complication of ischemic stroke treatment. The role of miR-155-5p in cerebral I/R injury has been studied, but the regulation of EP on miR-155-5p has not been reported.
Methods: The middle cerebral artery occlusion (MCAO) mice were used to investigate the role of EP in cerebral I/R injury. Longa and modified neurological severity scores (mNSS) were used to evaluate neurological impairment. HE staining and TUNEL staining were used to evaluate brain injury. The expressions of miR-155-5p, Yin Yang 1 (YY1) and p53 were detected by qRT-PCR. The expressions of related proteins were detected by western blot. The binding of YY1 to miR- 155-5p was verified by dual-luciferase reporter assay and chromatin immunoprecipitation (ChIP) assay. Mice brain microvascular endothelial cells (BMECs) were isolated and cultured for in vitro experiments. Oxygen-glucose deprivation/reoxygenation (OGD/R) was used to verify the role of YY1, p53 and miR-155-5p in cerebral I/R injury in vitro.
Results: MCAO modeling induced brain injury, apoptosis, and increased levels of miR-155-5p, YY1, and p53. EP markedly alleviated brain injury and reduced levels of miR-155-5p, p53, and YY1. miR-155 agomir markedly increased the expression of miR-155-5p and p53. miR-155 antagomir decreased the levels of miR-155-5p and p53. Dual-luciferase reporter and ChIP assay verified that YY1 regulated miR-155-5p expression. YY1 shNRA greatly decreased miR-155-5p and p53. Inhibition of p53 decreased miR-155-5p expression. Both miR-155-5p inhibitor and YY1 shRNA promoted proliferation, inhibited apoptosis, and decreased levels of ICAM-1 and Eselectin of OGD/R-treated BMECs. Inhibition of p53 strengthened the effect of miR-155-5p inhibitor and YY1 shNRA on BMECs.
Conclusion: Electroacupuncture pretreatment alleviates cerebral ischemia-reperfusion injury by regulating the YY1/p53/miR-155-5p axis.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.116.025250] [PMID: 28052979]
[http://dx.doi.org/10.1038/s41598-022-05288-7 ] [PMID: 35110569]
[http://dx.doi.org/10.1161/CIR.0000000000000757] [PMID: 31992061]
[http://dx.doi.org/10.1038/s41572-019-0118-8 ] [PMID: 31601801]
[http://dx.doi.org/10.1038/s41419-021-03725-5] [PMID: 33953171]
[http://dx.doi.org/10.1007/s12035-012-8344-z] [PMID: 23011809]
[http://dx.doi.org/10.3390/ijms21186728] [PMID: 32937836]
[http://dx.doi.org/10.1038/s41580-018-0045-7] [PMID: 30108335]
[http://dx.doi.org/10.3892/mmr.2020.11325] [PMID: 32705253]
[http://dx.doi.org/10.7150/thno.47677] [PMID: 32802196]
[http://dx.doi.org/10.1016/j.phrs.2020.104718] [PMID: 32084559]
[http://dx.doi.org/10.1155/2022/3494262] [PMID: 35401931]
[http://dx.doi.org/10.1080/21655979.2020.1729322] [PMID: 32050841]
[http://dx.doi.org/10.1002/jnr.24101] [PMID: 28609584]
[http://dx.doi.org/10.1007/s13311-018-0665-9] [PMID: 30225790]
[http://dx.doi.org/10.18388/abp.2020_6095] [PMID: 36441582]
[http://dx.doi.org/10.15806/j.issn.2311-8571.2014.0012]
[http://dx.doi.org/10.1155/2013/319734] [PMID: 23864884]
[http://dx.doi.org/10.1177/0271678X17697988] [PMID: 28281385]
[http://dx.doi.org/10.1186/s12906-017-2064-x ] [PMID: 29284465]
[http://dx.doi.org/10.1080/15548627.2021.1886720] [PMID: 33622188]
[http://dx.doi.org/10.4314/ajtcam.v11i3.5] [PMID: 25371560]
[http://dx.doi.org/10.18632/aging.103420] [PMID: 32620714]
[http://dx.doi.org/10.1016/j.neuropharm.2019.107682] [PMID: 31278927]
[http://dx.doi.org/10.1016/j.jbc.2021.100537] [PMID: 33722608]
[http://dx.doi.org/10.1128/MCB.16.10.5933] [PMID: 8816507]
[http://dx.doi.org/10.1016/j.neuron.2014.08.052] [PMID: 25233317]
[http://dx.doi.org/10.1016/S1474-4422(09)70023-7] [PMID: 19233730]
[http://dx.doi.org/10.1371/journal.pone.0140772] [PMID: 26473731]
[http://dx.doi.org/10.1155/2020/3495836 ] [PMID: 32256638]
[http://dx.doi.org/10.13702/j.1000-0607.190307] [PMID: 31867904]
[http://dx.doi.org/10.3389/fncel.2020.00134] [PMID: 32477073]
[http://dx.doi.org/10.1186/s10020-019-0091-4] [PMID: 31117961]
[http://dx.doi.org/10.1016/j.neuroscience.2017.04.017] [PMID: 28433650]
[http://dx.doi.org/10.3389/fneur.2013.00032] [PMID: 23565108]
[http://dx.doi.org/10.1155/2017/7150376] [PMID: 28690765]
[http://dx.doi.org/10.4061/2011/846716] [PMID: 21716663]
[http://dx.doi.org/10.3389/fneur.2017.00467] [PMID: 28936196]
[http://dx.doi.org/10.3389/fphar.2021.561237] [PMID: 33927611]
[http://dx.doi.org/10.1016/j.transproceed.2018.08.060] [PMID: 30577275]
[http://dx.doi.org/10.3892/ijmm.2022.5172] [PMID: 35795997]
[http://dx.doi.org/10.22038/ijbms.2019.34853.8270] [PMID: 31807249]
[http://dx.doi.org/10.1007/s11626-019-00375-y] [PMID: 31286366]
[PMID: 8546203]
[http://dx.doi.org/10.1186/s12931-019-1223-7] [PMID: 31703732]
[http://dx.doi.org/10.1016/j.biopha.2018.09.082] [PMID: 30248537]
[http://dx.doi.org/10.1016/j.cellsig.2016.02.006] [PMID: 26876786]
[http://dx.doi.org/10.3892/ijmm.2016.2526] [PMID: 26985867]
[http://dx.doi.org/10.17816/onco107182]
[http://dx.doi.org/10.1186/s12967-018-1486-7] [PMID: 29848325]
[http://dx.doi.org/10.13865/j.cnki.cjbmb.2023.06.1027]